W hen a material is at high temperature, it emits light -a phenomenon called incandescence. This is how tungsten filaments in light bulbs produce light. Yet, for most applications, these thermal sources of light are inefficient because they radiate over a broad spectrum. Writing in Physical Review Letters, Liu et al. 1 describe how metamaterials can be used to design a thermal source that has a controlled, narrow emission spectrum in the infrared regime. Meta materials are materials that have been engineered to contain nanostructures that give them novel properties.
As Max Planck demonstrated in 1900, at thermal equilibrium, the radiation spectrum is independent of the material from which an object is made or its geometry, and depends only on temperature. However, in a nonequili brium situation such as that of a light bulb, the spectrum is modified by the properties of the source's mater ial. Progress in making incandescent light sources has thus been limited to choosing the best available material. So technologies based on phenomena other than incandescence are used to produce more efficient sources than thermal emitters, such as light-emitting diodes or fluorescent tubes for lighting applications. Liu and colleagues' finding -that by using metamaterials it is possible to engineer the emission spectrum of an incandescent source in the infraredpaves the way for new applications for thermal sources. The authors describe sources that emit light at one or two wavelengths, or over a controlled spectral band, thus demonstrating good control of the emission spectrum. So how does it work?
The key to understanding the design of a thermal source is to apply Kirchhoff 's law. This states that the thermal emission produced by a device is proportional to its absorptivity. Although it was introduced historically as a principle, the law has been mathematically derived 2, 3 , and so we now know that it is valid for any absorbing structure. Hence, designing an efficient emitter amounts to designing an efficient absorber, or in other words, to making light enter an absorbing structure without being reflected. With the development of nanophotonics, there has been a blossoming of new ideas for thermal sources, such as materials with periodic structure 4, 5 combined with surface resonances 6 , multilayer systems 7 , metallo dielectric systems 8 and nanowires 9 . Such structures allow the absorption spectrum and the direction of emission to be controlled.
A standard technique for obtaining large absorption/emission is to use a thin metallic film separated from a mirror by a thin transparent layer. It was first introduced to provide anti-reflection coatings at radar frequencies (the 'Salisbury screen' concept) and is often used in infrared detectors. By replacing the thin film with small disks, quasi-mono chromatic absorbers/emitters have been obtained 10 . Liu et al. 1 now introduce a meta material that consists of a periodic array of metallic crosses separated from a metallic mirror by a transparent, thin, insulating layer. The crosses are useful because they allow the emission frequency to be tuned by changing the length of their arms, just as the pitch of an organ pipe depends on the pipe's length. Interestingly, the authors show that it is possible to generate two absorption frequencies by combining two types of cross, each type having a different arm length (Fig. 1) . They demonstrate an almost 100% absorption/ emission for the two frequencies.
This large absorption might at first seem surprising, because crosses absorbing at one frequency cover only half of the sample's surface and so would be expected to absorb only half of the incident radiation. This apparent paradox is easily resolved by recognizing that, at subwavelength scales, light cannot be described in terms of optical rays propagating along straight lines. A cross illuminated at its peak absorption frequency (resonant absorption) can absorb as much radiation as an opaque disk that has an area (the 'absorption cross-section') much larger than the area of the cross. For example, the absorption cross-section of 
2 /2π, which is much larger than the size of the atom. Hence, it is possible to pack together several subwavelength-sized crosses that have different absorption frequencies but do not cover the entire sample's surface and still attain almost total absorption for all of these frequencies. This property is the key to the design of broad-spectrum absorbers/emitters using metamaterials.
What applications might there be for incandescent sources with controlled infrared spectra? Infrared thermal sources are usually used for identifying gases. Most gases have specific infrared absorption lines, so producing infrared sources designed to emit at these frequencies is an attractive idea. Another promising application is the development of thermophotovoltaic solar cells, which convert solar radiation into electricity. One of the main limitations to the efficiency of photovoltaic solar cells is the mismatch between the broad emission spectrum of the Sun and the narrow absorption spectrum of the photovoltaic cell. The thermophotovoltaic concept is based on having a broadband absorber that captures the Sun's energy and heats a secondary source that has an emission peak perfectly matched with the absorption spectrum of the solar cell.
Finally, Liu and colleagues' study 1 raises the prospect of active control of the thermal emission. The only active control of emission achieved so far has been based on modifying the temperature of the source. This is usually a slow process because temperature changes are limited by the time needed for heat to diffuse through the system. But if the resonant absorptivity can be controlled by electrically or optically tuning a resonant absorber, a new generation of smart emitters can be envisaged. 
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Why tumours eat tryptophan
Tumours increase their consumption of the amino acid tryptophan to evade immune control. But how does this work? A study shows that the main product of this consumption binds to a receptor involved in the immune system. See Article p.197
here is mounting evidence that fastgrowing 'progressive' cancers occur because of a failure of the immune system to maintain control over budding tumours. The ability of cancers to escape immune responses is therefore attracting increasing attention, with numerous studies now pointing, perhaps surprisingly, to the consumption of the amino acid tryptophan as a critical factor in progressive cancer. On page 197 of this issue, Opitz et al. 1 advance the field with their finding that many cancers upregulate a liver enzyme, tryptophan dioxygenase, to drive tryptophan consumption. What's more, the authors find that the primary product of this process, kynurenine, is an endogenous ligand for the aryl hydrocarbon receptor, which mediates invasive tumour growth. This second finding links the fields of toxicology, immunology and cancer biology in new ways, and may help to explain how elevated tryptophan consumption helps tumours to overcome immune barriers to cancer progression.
Cancer has its roots in altered gene structure and expression, but the tissue microenvironment in which a cancer arises poses a huge barrier to its development and progression. In particular, the complex interplay between cancer cells and nearby immune cells may be one of the most important determinants of whether an early cancer is destroyed by the immune system, persists in a dormant or slowgrowing state (such tumours are often localized and treatable), or progresses to a clinically challenging invasive or metastatic state.
Immune escape represents a budding tumour's victory in its constant thrust and parry with the immune system, which detects accumulating genetic damage in cancer cells. This battle, which is coordinated with oncogenic processes, selects for cancer cells that can resist immune detection or eradication. Immune escape therefore drives the development of tumours towards increasingly aggressive forms 2 . Intriguingly, many pathways of immune escape involve active suppression of the immune system by tumour cells, implying that disruption of these suppressive pathways could restore immune attack. One such pathway that is of emerging importance in cancer involves the consumption of tryptophan and generation of kynurenine by the indoleamine 2,3-dioxygenase enzymes IDO and IDO2, and also by tryptophan dioxygenase (TDO), as Opitz et al. 1 report. The fundamental role of IDO in immune tolerance was recognized several years before its connections to cancer, and it is by far the most broadly expressed and studied of the tryptophan-metabolizing enzymes 3, 4 . IDO's action leads to tryptophan depletion and kynurenine generation, which cooperate to inhibit the activation of immune cells known as T cells through various mechanisms that also affect the activities of other classes of
